Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
Is Behçet disease uncommon or rather underdiagnosed? When should it be suspected?
Gülen Hatemi, MD:
The prevalence of Behçet syndrome shows great variation across geographies. It is much more common in Turkey, Iran, Middle Eastern countries, and countries at the other end of the Silk Road: Japan, Korea, and China. In these countries it is frequently recognized much earlier than in countries where the prevalence is lower.
So in a European country, especially in the north of Europe, where the prevalence of Behçet syndrome is quite low, the disease may be underdiagnosed.
Monitoring disease activity in GCA
How to monitor disease activity in patients with giant cell arteritis (GCA)? Is it useful to measure interleukin 6 levels, or are inflammatory markers (ESR, CRP) sufficient?
Effects of diet in patients with gout
Has evidence-based medicine been able to prove beneficial or harmful effects of any particular diets in patients with gout?
Axial SpA: diagnostics, treatment, disease activity
Dr Filip Van den Bosch, associate professor of rheumatology at Ghent University, Belgium, reviews the current diagnostic methods, treatment, and activity measurement used in patients with nonradiographic axial spondyloarthritis in a conversation with Dr Mariusz Korkosz.
Polymyalgia rheumatica: current management
A lecture by Prof. Bhaskar Dasgupta, from Southend University Hospital, UK, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.